Cargando…
Con: should asymptomatic patients with moderate-to-severe OSA be treated?
In a large proportion of patients with moderate–severe OSA who do not report daytime sleepiness there is no convincing evidence at present that CPAP or similar treatments provide benefit for associated medical disorders, such as hypertension and diabetes http://ow.ly/qqqi30nok4d
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395989/ https://www.ncbi.nlm.nih.gov/pubmed/30838055 http://dx.doi.org/10.1183/20734735.0347-2018 |
_version_ | 1783399181317046272 |
---|---|
author | Vakulin, Andrew Chai-Coetzer, Ching Li McEvoy, R. Doug |
author_facet | Vakulin, Andrew Chai-Coetzer, Ching Li McEvoy, R. Doug |
author_sort | Vakulin, Andrew |
collection | PubMed |
description | In a large proportion of patients with moderate–severe OSA who do not report daytime sleepiness there is no convincing evidence at present that CPAP or similar treatments provide benefit for associated medical disorders, such as hypertension and diabetes http://ow.ly/qqqi30nok4d |
format | Online Article Text |
id | pubmed-6395989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-63959892019-03-05 Con: should asymptomatic patients with moderate-to-severe
OSA be treated? Vakulin, Andrew Chai-Coetzer, Ching Li McEvoy, R. Doug Breathe (Sheff) Editorials In a large proportion of patients with moderate–severe OSA who do not report daytime sleepiness there is no convincing evidence at present that CPAP or similar treatments provide benefit for associated medical disorders, such as hypertension and diabetes http://ow.ly/qqqi30nok4d European Respiratory Society 2019-03 /pmc/articles/PMC6395989/ /pubmed/30838055 http://dx.doi.org/10.1183/20734735.0347-2018 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/ Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Editorials Vakulin, Andrew Chai-Coetzer, Ching Li McEvoy, R. Doug Con: should asymptomatic patients with moderate-to-severe OSA be treated? |
title | Con: should asymptomatic patients with moderate-to-severe
OSA be treated? |
title_full | Con: should asymptomatic patients with moderate-to-severe
OSA be treated? |
title_fullStr | Con: should asymptomatic patients with moderate-to-severe
OSA be treated? |
title_full_unstemmed | Con: should asymptomatic patients with moderate-to-severe
OSA be treated? |
title_short | Con: should asymptomatic patients with moderate-to-severe
OSA be treated? |
title_sort | con: should asymptomatic patients with moderate-to-severe
osa be treated? |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395989/ https://www.ncbi.nlm.nih.gov/pubmed/30838055 http://dx.doi.org/10.1183/20734735.0347-2018 |
work_keys_str_mv | AT vakulinandrew conshouldasymptomaticpatientswithmoderatetosevereosabetreated AT chaicoetzerchingli conshouldasymptomaticpatientswithmoderatetosevereosabetreated AT mcevoyrdoug conshouldasymptomaticpatientswithmoderatetosevereosabetreated |